Right ventricular injury in patients with COVID-19-related acute respiratory distress syndrome (ARDS) eligible for extracorporeal membrane oxygenation (ECMO) support: a multicenter retrospective study
Main finding · 90-day mortalityResult — go to the resultHazard ratio 1.92 CI 1.10–3.37Authors' conclusion
Among COVID-19-associated ARDS patients who met the EOLIA criteria, those with significant RV pressure overload had a particularly poor outcome.
Study context
- Population
- Patients with confirmed SARS-CoV-2 infection and ARDS with available echocardiography, 3 French intensive care units (ICUs) of teaching hospitals, March 2020–March 202118 on ECMO excluded
- Participants
- 283 patients
- Exposure
- EOLIA + RV injury (RVI) + vs EOLIA + RVI - vs EOLIA -
- EOLIA -n = 107reference
- EOLIA + RVI -n = 126
- EOLIA + RVI +n = 32
- Outcome
- Mortality
- Follow-up
- 90 days
Methodological detailsobservational, multicentre
- Observational
- Multicentre
Main finding
90-day mortality
Hazard ratio
1.92
CI 1.10–3.37
By group
RVI
HR 1.92 (CI 1.10–3.37)
As reported in the abstract
Observational data: associations, not effects.
Further findings
- Patients who received ECMO
- 18 (6.3%)
Original publication
Right ventricular injury in patients with COVID-19-related ARDS eligible for ECMO support: a multicenter retrospective study. Ann Intensive Care. Published 26 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →